nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—ABCC3—hematologic cancer	0.198	0.832	CbGaD
Nifedipine—ABCB1—hematologic cancer	0.0401	0.168	CbGaD
Nifedipine—CYP2A6—Methoxsalen—hematologic cancer	0.0107	0.0232	CbGbCtD
Nifedipine—ABCC2—Daunorubicin—hematologic cancer	0.00994	0.0216	CbGbCtD
Nifedipine—ABCC3—Vincristine—hematologic cancer	0.00914	0.0199	CbGbCtD
Nifedipine—CYP1A2—Anagrelide—hematologic cancer	0.00912	0.0199	CbGbCtD
Nifedipine—CYP1A1—Methoxsalen—hematologic cancer	0.00911	0.0199	CbGbCtD
Nifedipine—CYP2B6—Thiotepa—hematologic cancer	0.00893	0.0195	CbGbCtD
Nifedipine—CYP1A1—Bortezomib—hematologic cancer	0.00867	0.0189	CbGbCtD
Nifedipine—ABCC3—Cisplatin—hematologic cancer	0.00853	0.0186	CbGbCtD
Nifedipine—ABCC3—Etoposide—hematologic cancer	0.00838	0.0183	CbGbCtD
Nifedipine—CYP1A1—Daunorubicin—hematologic cancer	0.00829	0.0181	CbGbCtD
Nifedipine—CYP2A6—Ifosfamide—hematologic cancer	0.00778	0.017	CbGbCtD
Nifedipine—CYP1A1—Thalidomide—hematologic cancer	0.00755	0.0165	CbGbCtD
Nifedipine—CYP1A1—Dacarbazine—hematologic cancer	0.00649	0.0141	CbGbCtD
Nifedipine—CYP2E1—Thalidomide—hematologic cancer	0.00583	0.0127	CbGbCtD
Nifedipine—ABCC3—Doxorubicin—hematologic cancer	0.00571	0.0124	CbGbCtD
Nifedipine—CYP2C9—Bexarotene—hematologic cancer	0.00569	0.0124	CbGbCtD
Nifedipine—ABCC3—Methotrexate—hematologic cancer	0.00554	0.0121	CbGbCtD
Nifedipine—ABCB1—Lenalidomide—hematologic cancer	0.00553	0.012	CbGbCtD
Nifedipine—CYP3A7—Ifosfamide—hematologic cancer	0.00532	0.0116	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00532	0.0116	CbGbCtD
Nifedipine—CYP2A6—Prednisolone—hematologic cancer	0.00519	0.0113	CbGbCtD
Nifedipine—CYP1A1—Dasatinib—hematologic cancer	0.0051	0.0111	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00508	0.0111	CbGbCtD
Nifedipine—CYP3A7—Imatinib—hematologic cancer	0.00508	0.0111	CbGbCtD
Nifedipine—CYP2B6—Ifosfamide—hematologic cancer	0.00507	0.011	CbGbCtD
Nifedipine—CYP2E1—Dacarbazine—hematologic cancer	0.00502	0.0109	CbGbCtD
Nifedipine—CYP2C8—Bortezomib—hematologic cancer	0.005	0.0109	CbGbCtD
Nifedipine—CYP3A5—Daunorubicin—hematologic cancer	0.00498	0.0108	CbGbCtD
Nifedipine—CYP2D6—Lomustine—hematologic cancer	0.00484	0.0105	CbGbCtD
Nifedipine—CYP1A2—Carmustine—hematologic cancer	0.00479	0.0104	CbGbCtD
Nifedipine—ABCC2—Irinotecan—hematologic cancer	0.00475	0.0104	CbGbCtD
Nifedipine—CYP2C9—Idarubicin—hematologic cancer	0.00472	0.0103	CbGbCtD
Nifedipine—CYP3A5—Thalidomide—hematologic cancer	0.00453	0.00987	CbGbCtD
Nifedipine—CYP2B6—Nilotinib—hematologic cancer	0.0044	0.00958	CbGbCtD
Nifedipine—CYP3A5—Teniposide—hematologic cancer	0.00432	0.00942	CbGbCtD
Nifedipine—CYP2D6—Idarubicin—hematologic cancer	0.00431	0.0094	CbGbCtD
Nifedipine—ABCC2—Vinblastine—hematologic cancer	0.00423	0.00921	CbGbCtD
Nifedipine—ABCC2—Vincristine—hematologic cancer	0.00416	0.00905	CbGbCtD
Nifedipine—CYP1A2—Methoxsalen—hematologic cancer	0.00407	0.00887	CbGbCtD
Nifedipine—CYP3A5—Ifosfamide—hematologic cancer	0.00399	0.00869	CbGbCtD
Nifedipine—CYP2E1—Mitoxantrone—hematologic cancer	0.00389	0.00848	CbGbCtD
Nifedipine—ABCC2—Cisplatin—hematologic cancer	0.00388	0.00844	CbGbCtD
Nifedipine—CYP1A2—Bortezomib—hematologic cancer	0.00387	0.00844	CbGbCtD
Nifedipine—CYP2C8—Ifosfamide—hematologic cancer	0.00384	0.00836	CbGbCtD
Nifedipine—CYP3A5—Imatinib—hematologic cancer	0.00381	0.0083	CbGbCtD
Nifedipine—ABCC2—Etoposide—hematologic cancer	0.00381	0.00829	CbGbCtD
Nifedipine—CYP1A2—Daunorubicin—hematologic cancer	0.0037	0.00807	CbGbCtD
Nifedipine—CYP2D6—Hydroxyurea—hematologic cancer	0.00367	0.00799	CbGbCtD
Nifedipine—CYP1A2—Alitretinoin—hematologic cancer	0.00363	0.00791	CbGbCtD
Nifedipine—CYP2C9—Bortezomib—hematologic cancer	0.00349	0.0076	CbGbCtD
Nifedipine—CYP1A2—Thalidomide—hematologic cancer	0.00337	0.00735	CbGbCtD
Nifedipine—CYP2C8—Nilotinib—hematologic cancer	0.00333	0.00726	CbGbCtD
Nifedipine—CYP3A4—Bexarotene—hematologic cancer	0.00331	0.00721	CbGbCtD
Nifedipine—ABCB1—Daunorubicin—hematologic cancer	0.00324	0.00706	CbGbCtD
Nifedipine—CYP2D6—Bortezomib—hematologic cancer	0.00319	0.00695	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00317	0.00691	CbGbCtD
Nifedipine—CYP3A7—Irinotecan—hematologic cancer	0.00317	0.00691	CbGbCtD
Nifedipine—ABCB1—Alitretinoin—hematologic cancer	0.00317	0.00691	CbGbCtD
Nifedipine—ABCC2—Dexamethasone—hematologic cancer	0.00313	0.00682	CbGbCtD
Nifedipine—CYP3A4—Busulfan—hematologic cancer	0.00308	0.0067	CbGbCtD
Nifedipine—CYP3A4—Lomustine—hematologic cancer	0.00308	0.0067	CbGbCtD
Nifedipine—CYP3A5—Dasatinib—hematologic cancer	0.00306	0.00667	CbGbCtD
Nifedipine—CYP2A6—Dexamethasone—hematologic cancer	0.00306	0.00666	CbGbCtD
Nifedipine—CYP2C9—Thalidomide—hematologic cancer	0.00304	0.00662	CbGbCtD
Nifedipine—CYP2B6—Irinotecan—hematologic cancer	0.00302	0.00658	CbGbCtD
Nifedipine—CYP1A2—Dacarbazine—hematologic cancer	0.0029	0.00632	CbGbCtD
Nifedipine—CYP2C9—Teniposide—hematologic cancer	0.0029	0.00632	CbGbCtD
Nifedipine—CYP1A2—Imatinib—hematologic cancer	0.00284	0.00618	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00277	0.00604	CbGbCtD
Nifedipine—CYP3A7—Vincristine—hematologic cancer	0.00277	0.00604	CbGbCtD
Nifedipine—CYP3A4—Thiotepa—hematologic cancer	0.00274	0.00598	CbGbCtD
Nifedipine—CYP2C9—Ifosfamide—hematologic cancer	0.00268	0.00583	CbGbCtD
Nifedipine—CYP1A1—Dexamethasone—hematologic cancer	0.00261	0.00569	CbGbCtD
Nifedipine—ABCC2—Doxorubicin—hematologic cancer	0.0026	0.00566	CbGbCtD
Nifedipine—CYP2C9—Imatinib—hematologic cancer	0.00256	0.00557	CbGbCtD
Nifedipine—ABCC2—Methotrexate—hematologic cancer	0.00252	0.00548	CbGbCtD
Nifedipine—ABCB1—Imatinib—hematologic cancer	0.00248	0.0054	CbGbCtD
Nifedipine—CYP2B6—Cisplatin—hematologic cancer	0.00246	0.00537	CbGbCtD
Nifedipine—CYP2E1—Etoposide—hematologic cancer	0.00245	0.00535	CbGbCtD
Nifedipine—CYP3A5—Irinotecan—hematologic cancer	0.00238	0.00519	CbGbCtD
Nifedipine—CYP2D6—Imatinib—hematologic cancer	0.00234	0.00509	CbGbCtD
Nifedipine—CYP2C9—Nilotinib—hematologic cancer	0.00232	0.00506	CbGbCtD
Nifedipine—CYP1A2—Dasatinib—hematologic cancer	0.00228	0.00496	CbGbCtD
Nifedipine—ABCB1—Nilotinib—hematologic cancer	0.00225	0.00491	CbGbCtD
Nifedipine—ABCB1—Vinorelbine—hematologic cancer	0.00224	0.00487	CbGbCtD
Nifedipine—CYP3A4—Methoxsalen—hematologic cancer	0.00213	0.00465	CbGbCtD
Nifedipine—CYP2D6—Nilotinib—hematologic cancer	0.00212	0.00463	CbGbCtD
Nifedipine—CYP2D6—Vinorelbine—hematologic cancer	0.00211	0.00459	CbGbCtD
Nifedipine—CYP3A7—Dexamethasone—hematologic cancer	0.00209	0.00455	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00209	0.00455	CbGbCtD
Nifedipine—CYP3A5—Vincristine—hematologic cancer	0.00208	0.00453	CbGbCtD
Nifedipine—CYP3A4—Bortezomib—hematologic cancer	0.00203	0.00442	CbGbCtD
Nifedipine—CYP2E1—Dexamethasone—hematologic cancer	0.00202	0.0044	CbGbCtD
Nifedipine—ABCB1—Dasatinib—hematologic cancer	0.00199	0.00434	CbGbCtD
Nifedipine—CYP2B6—Dexamethasone—hematologic cancer	0.00199	0.00434	CbGbCtD
Nifedipine—ABCB1—Mitoxantrone—hematologic cancer	0.00197	0.00429	CbGbCtD
Nifedipine—CYP3A4—Daunorubicin—hematologic cancer	0.00194	0.00423	CbGbCtD
Nifedipine—CYP3A5—Etoposide—hematologic cancer	0.00191	0.00415	CbGbCtD
Nifedipine—CYP2C8—Etoposide—hematologic cancer	0.00183	0.00399	CbGbCtD
Nifedipine—ABCB1—Betamethasone—hematologic cancer	0.00175	0.00382	CbGbCtD
Nifedipine—ABCB1—Gemcitabine—hematologic cancer	0.00174	0.00379	CbGbCtD
Nifedipine—ABCB1—Prednisolone—hematologic cancer	0.00173	0.00377	CbGbCtD
Nifedipine—CYP3A4—Cytarabine—hematologic cancer	0.00171	0.00373	CbGbCtD
Nifedipine—CYP3A4—Teniposide—hematologic cancer	0.00169	0.00367	CbGbCtD
Nifedipine—CYP2B6—Doxorubicin—hematologic cancer	0.00165	0.0036	CbGbCtD
Nifedipine—ABCB1—Prednisone—hematologic cancer	0.00163	0.00356	CbGbCtD
Nifedipine—CYP3A5—Dexamethasone—hematologic cancer	0.00157	0.00342	CbGbCtD
Nifedipine—CYP3A4—Ifosfamide—hematologic cancer	0.00156	0.00339	CbGbCtD
Nifedipine—ABCB1—Irinotecan—hematologic cancer	0.00155	0.00338	CbGbCtD
Nifedipine—CYP2C8—Dexamethasone—hematologic cancer	0.00151	0.00328	CbGbCtD
Nifedipine—CYP3A4—Imatinib—hematologic cancer	0.00149	0.00324	CbGbCtD
Nifedipine—CYP1A2—Etoposide—hematologic cancer	0.00142	0.00309	CbGbCtD
Nifedipine—CYP3A4—Ruxolitinib—hematologic cancer	0.0014	0.00305	CbGbCtD
Nifedipine—ABCB1—Vinblastine—hematologic cancer	0.00138	0.003	CbGbCtD
Nifedipine—ABCB1—Vincristine—hematologic cancer	0.00135	0.00295	CbGbCtD
Nifedipine—CYP3A4—Nilotinib—hematologic cancer	0.00135	0.00294	CbGbCtD
Nifedipine—CYP3A4—Vinorelbine—hematologic cancer	0.00134	0.00292	CbGbCtD
Nifedipine—CYP2C9—Cisplatin—hematologic cancer	0.0013	0.00284	CbGbCtD
Nifedipine—CYP2D6—Vinblastine—hematologic cancer	0.0013	0.00283	CbGbCtD
Nifedipine—ABCB1—Cisplatin—hematologic cancer	0.00126	0.00275	CbGbCtD
Nifedipine—ABCB1—Etoposide—hematologic cancer	0.00124	0.0027	CbGbCtD
Nifedipine—CYP3A4—Triamcinolone—hematologic cancer	0.00123	0.00267	CbGbCtD
Nifedipine—CYP3A4—Dasatinib—hematologic cancer	0.00119	0.0026	CbGbCtD
Nifedipine—CYP3A4—Mitoxantrone—hematologic cancer	0.00118	0.00257	CbGbCtD
Nifedipine—CYP2C9—Dexamethasone—hematologic cancer	0.00105	0.00229	CbGbCtD
Nifedipine—CYP3A4—Betamethasone—hematologic cancer	0.00105	0.00229	CbGbCtD
Nifedipine—CYP3A4—Prednisolone—hematologic cancer	0.00104	0.00226	CbGbCtD
Nifedipine—ABCB1—Dexamethasone—hematologic cancer	0.00102	0.00222	CbGbCtD
Nifedipine—CYP3A4—Prednisone—hematologic cancer	0.000979	0.00213	CbGbCtD
Nifedipine—CYP2D6—Dexamethasone—hematologic cancer	0.000962	0.00209	CbGbCtD
Nifedipine—CYP3A4—Irinotecan—hematologic cancer	0.000929	0.00202	CbGbCtD
Nifedipine—ABCB1—Doxorubicin—hematologic cancer	0.000847	0.00184	CbGbCtD
Nifedipine—CYP3A4—Vinblastine—hematologic cancer	0.000826	0.0018	CbGbCtD
Nifedipine—ABCB1—Methotrexate—hematologic cancer	0.00082	0.00179	CbGbCtD
Nifedipine—CYP3A4—Vincristine—hematologic cancer	0.000812	0.00177	CbGbCtD
Nifedipine—CYP2D6—Doxorubicin—hematologic cancer	0.000798	0.00174	CbGbCtD
Nifedipine—CACNA1H—gonad—hematologic cancer	0.000761	0.0293	CbGeAlD
Nifedipine—CYP3A4—Etoposide—hematologic cancer	0.000744	0.00162	CbGbCtD
Nifedipine—ABCC3—hematopoietic system—hematologic cancer	0.000694	0.0267	CbGeAlD
Nifedipine—CYP3A4—Dexamethasone—hematologic cancer	0.000611	0.00133	CbGbCtD
Nifedipine—CACNA2D1—bone marrow—hematologic cancer	0.000569	0.0219	CbGeAlD
Nifedipine—CACNB2—lung—hematologic cancer	0.000549	0.0211	CbGeAlD
Nifedipine—CACNA1H—testis—hematologic cancer	0.000548	0.0211	CbGeAlD
Nifedipine—CACNB2—testis—hematologic cancer	0.000518	0.0199	CbGeAlD
Nifedipine—CACNA2D1—lung—hematologic cancer	0.000515	0.0198	CbGeAlD
Nifedipine—CYP3A4—Doxorubicin—hematologic cancer	0.000507	0.0011	CbGbCtD
Nifedipine—CALM2—hematopoietic system—hematologic cancer	0.000501	0.0193	CbGeAlD
Nifedipine—CALM1—hematopoietic system—hematologic cancer	0.000499	0.0192	CbGeAlD
Nifedipine—CACNA2D1—testis—hematologic cancer	0.000486	0.0187	CbGeAlD
Nifedipine—CACNA1D—lung—hematologic cancer	0.00048	0.0185	CbGeAlD
Nifedipine—ABCC3—blood—hematologic cancer	0.000459	0.0177	CbGeAlD
Nifedipine—CACNA1D—testis—hematologic cancer	0.000453	0.0174	CbGeAlD
Nifedipine—CACNA1C—lung—hematologic cancer	0.000443	0.017	CbGeAlD
Nifedipine—CYP2A6—lung—hematologic cancer	0.00043	0.0165	CbGeAlD
Nifedipine—CALM3—blood—hematologic cancer	0.000423	0.0163	CbGeAlD
Nifedipine—CACNA1C—testis—hematologic cancer	0.000418	0.0161	CbGeAlD
Nifedipine—CYP2C8—hematopoietic system—hematologic cancer	0.000416	0.016	CbGeAlD
Nifedipine—CALM3—bone marrow—hematologic cancer	0.000409	0.0158	CbGeAlD
Nifedipine—ABCC3—lung—hematologic cancer	0.000403	0.0155	CbGeAlD
Nifedipine—CACNA1H—lymph node—hematologic cancer	0.000397	0.0153	CbGeAlD
Nifedipine—CYP1A2—hematopoietic system—hematologic cancer	0.000389	0.015	CbGeAlD
Nifedipine—CYP1A1—hematopoietic system—hematologic cancer	0.000384	0.0148	CbGeAlD
Nifedipine—CALM2—gonad—hematologic cancer	0.000381	0.0147	CbGeAlD
Nifedipine—ABCC3—testis—hematologic cancer	0.00038	0.0146	CbGeAlD
Nifedipine—CALM1—gonad—hematologic cancer	0.00038	0.0146	CbGeAlD
Nifedipine—CACNB2—lymph node—hematologic cancer	0.000375	0.0144	CbGeAlD
Nifedipine—CYP3A5—hematopoietic system—hematologic cancer	0.000375	0.0144	CbGeAlD
Nifedipine—CYP2B6—hematopoietic system—hematologic cancer	0.000373	0.0143	CbGeAlD
Nifedipine—CALM3—lung—hematologic cancer	0.000371	0.0143	CbGeAlD
Nifedipine—CYP2C9—hematopoietic system—hematologic cancer	0.000369	0.0142	CbGeAlD
Nifedipine—ABCC2—blood—hematologic cancer	0.000367	0.0141	CbGeAlD
Nifedipine—CACNA2D1—lymph node—hematologic cancer	0.000352	0.0136	CbGeAlD
Nifedipine—CALM3—testis—hematologic cancer	0.00035	0.0135	CbGeAlD
Nifedipine—CYP2E1—hematopoietic system—hematologic cancer	0.00035	0.0135	CbGeAlD
Nifedipine—CALM2—blood—hematologic cancer	0.000332	0.0128	CbGeAlD
Nifedipine—CALM1—blood—hematologic cancer	0.000331	0.0127	CbGeAlD
Nifedipine—CACNA1D—lymph node—hematologic cancer	0.000328	0.0126	CbGeAlD
Nifedipine—CALM2—bone marrow—hematologic cancer	0.000321	0.0124	CbGeAlD
Nifedipine—CALM1—bone marrow—hematologic cancer	0.00032	0.0123	CbGeAlD
Nifedipine—ABCC2—testis—hematologic cancer	0.000304	0.0117	CbGeAlD
Nifedipine—CACNA1C—lymph node—hematologic cancer	0.000303	0.0117	CbGeAlD
Nifedipine—CALM2—lung—hematologic cancer	0.000291	0.0112	CbGeAlD
Nifedipine—CALM1—lung—hematologic cancer	0.00029	0.0112	CbGeAlD
Nifedipine—CYP2B6—gonad—hematologic cancer	0.000283	0.0109	CbGeAlD
Nifedipine—CYP3A4—hematopoietic system—hematologic cancer	0.000282	0.0108	CbGeAlD
Nifedipine—CYP2D6—hematopoietic system—hematologic cancer	0.000277	0.0107	CbGeAlD
Nifedipine—ABCC3—lymph node—hematologic cancer	0.000275	0.0106	CbGeAlD
Nifedipine—CYP2C8—blood—hematologic cancer	0.000275	0.0106	CbGeAlD
Nifedipine—CALM2—testis—hematologic cancer	0.000275	0.0106	CbGeAlD
Nifedipine—CALM1—testis—hematologic cancer	0.000274	0.0105	CbGeAlD
Nifedipine—CYP1A2—blood—hematologic cancer	0.000258	0.00992	CbGeAlD
Nifedipine—CYP1A1—blood—hematologic cancer	0.000254	0.00978	CbGeAlD
Nifedipine—CALM3—lymph node—hematologic cancer	0.000254	0.00976	CbGeAlD
Nifedipine—CYP3A5—blood—hematologic cancer	0.000249	0.00957	CbGeAlD
Nifedipine—CYP2B6—blood—hematologic cancer	0.000247	0.00951	CbGeAlD
Nifedipine—CYP2C9—blood—hematologic cancer	0.000245	0.00941	CbGeAlD
Nifedipine—CYP2E1—blood—hematologic cancer	0.000232	0.00892	CbGeAlD
Nifedipine—CYP2C8—testis—hematologic cancer	0.000228	0.00877	CbGeAlD
Nifedipine—CYP1A2—lung—hematologic cancer	0.000226	0.00869	CbGeAlD
Nifedipine—CYP1A1—lung—hematologic cancer	0.000223	0.00858	CbGeAlD
Nifedipine—ABCC2—lymph node—hematologic cancer	0.00022	0.00847	CbGeAlD
Nifedipine—CYP3A5—lung—hematologic cancer	0.000218	0.00839	CbGeAlD
Nifedipine—CYP2B6—lung—hematologic cancer	0.000217	0.00833	CbGeAlD
Nifedipine—CYP2B6—testis—hematologic cancer	0.000204	0.00786	CbGeAlD
Nifedipine—CYP2E1—lung—hematologic cancer	0.000203	0.00782	CbGeAlD
Nifedipine—ABCB1—hematopoietic system—hematologic cancer	0.000199	0.00767	CbGeAlD
Nifedipine—CALM2—lymph node—hematologic cancer	0.000199	0.00767	CbGeAlD
Nifedipine—CALM1—lymph node—hematologic cancer	0.000198	0.00763	CbGeAlD
Nifedipine—CYP2E1—testis—hematologic cancer	0.000192	0.00738	CbGeAlD
Nifedipine—CYP3A4—blood—hematologic cancer	0.000187	0.00718	CbGeAlD
Nifedipine—CYP2D6—blood—hematologic cancer	0.000184	0.00706	CbGeAlD
Nifedipine—CYP1A1—lymph node—hematologic cancer	0.000152	0.00587	CbGeAlD
Nifedipine—CYP2D6—testis—hematologic cancer	0.000152	0.00584	CbGeAlD
Nifedipine—ABCB1—gonad—hematologic cancer	0.000152	0.00583	CbGeAlD
Nifedipine—ABCB1—blood—hematologic cancer	0.000132	0.00508	CbGeAlD
Nifedipine—ABCB1—bone marrow—hematologic cancer	0.000128	0.00492	CbGeAlD
Nifedipine—ABCB1—lung—hematologic cancer	0.000116	0.00445	CbGeAlD
Nifedipine—ABCB1—testis—hematologic cancer	0.000109	0.0042	CbGeAlD
Nifedipine—ABCB1—lymph node—hematologic cancer	7.92e-05	0.00305	CbGeAlD
Nifedipine—Eye disorder—Doxorubicin—hematologic cancer	1.17e-05	6.67e-05	CcSEcCtD
Nifedipine—Ill-defined disorder—Methotrexate—hematologic cancer	1.16e-05	6.66e-05	CcSEcCtD
Nifedipine—Tinnitus—Doxorubicin—hematologic cancer	1.16e-05	6.66e-05	CcSEcCtD
Nifedipine—Anaemia—Methotrexate—hematologic cancer	1.16e-05	6.63e-05	CcSEcCtD
Nifedipine—Feeling abnormal—Dexamethasone—hematologic cancer	1.16e-05	6.63e-05	CcSEcCtD
Nifedipine—Feeling abnormal—Betamethasone—hematologic cancer	1.16e-05	6.63e-05	CcSEcCtD
Nifedipine—Flushing—Doxorubicin—hematologic cancer	1.16e-05	6.63e-05	CcSEcCtD
Nifedipine—Cardiac disorder—Doxorubicin—hematologic cancer	1.16e-05	6.63e-05	CcSEcCtD
Nifedipine—Flatulence—Epirubicin—hematologic cancer	1.16e-05	6.62e-05	CcSEcCtD
Nifedipine—Tension—Epirubicin—hematologic cancer	1.15e-05	6.59e-05	CcSEcCtD
Nifedipine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.15e-05	6.58e-05	CcSEcCtD
Nifedipine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.15e-05	6.58e-05	CcSEcCtD
Nifedipine—Dysgeusia—Epirubicin—hematologic cancer	1.15e-05	6.58e-05	CcSEcCtD
Nifedipine—Hypersensitivity—Triamcinolone—hematologic cancer	1.14e-05	6.53e-05	CcSEcCtD
Nifedipine—Nervousness—Epirubicin—hematologic cancer	1.14e-05	6.52e-05	CcSEcCtD
Nifedipine—Back pain—Epirubicin—hematologic cancer	1.14e-05	6.5e-05	CcSEcCtD
Nifedipine—Angiopathy—Doxorubicin—hematologic cancer	1.13e-05	6.48e-05	CcSEcCtD
Nifedipine—Malaise—Methotrexate—hematologic cancer	1.13e-05	6.47e-05	CcSEcCtD
Nifedipine—Dizziness—Etoposide—hematologic cancer	1.13e-05	6.47e-05	CcSEcCtD
Nifedipine—Muscle spasms—Epirubicin—hematologic cancer	1.13e-05	6.46e-05	CcSEcCtD
Nifedipine—Immune system disorder—Doxorubicin—hematologic cancer	1.13e-05	6.45e-05	CcSEcCtD
Nifedipine—Vertigo—Methotrexate—hematologic cancer	1.13e-05	6.45e-05	CcSEcCtD
Nifedipine—Mediastinal disorder—Doxorubicin—hematologic cancer	1.12e-05	6.43e-05	CcSEcCtD
Nifedipine—Leukopenia—Methotrexate—hematologic cancer	1.12e-05	6.42e-05	CcSEcCtD
Nifedipine—Chills—Doxorubicin—hematologic cancer	1.12e-05	6.41e-05	CcSEcCtD
Nifedipine—Urticaria—Betamethasone—hematologic cancer	1.12e-05	6.39e-05	CcSEcCtD
Nifedipine—Urticaria—Dexamethasone—hematologic cancer	1.12e-05	6.39e-05	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.12e-05	6.39e-05	CcSEcCtD
Nifedipine—Dizziness—Prednisolone—hematologic cancer	1.11e-05	6.38e-05	CcSEcCtD
Nifedipine—Arrhythmia—Doxorubicin—hematologic cancer	1.11e-05	6.38e-05	CcSEcCtD
Nifedipine—Asthenia—Triamcinolone—hematologic cancer	1.11e-05	6.36e-05	CcSEcCtD
Nifedipine—Body temperature increased—Betamethasone—hematologic cancer	1.11e-05	6.36e-05	CcSEcCtD
Nifedipine—Abdominal pain—Dexamethasone—hematologic cancer	1.11e-05	6.36e-05	CcSEcCtD
Nifedipine—Abdominal pain—Betamethasone—hematologic cancer	1.11e-05	6.36e-05	CcSEcCtD
Nifedipine—Body temperature increased—Dexamethasone—hematologic cancer	1.11e-05	6.36e-05	CcSEcCtD
Nifedipine—Nausea—Cisplatin—hematologic cancer	1.11e-05	6.34e-05	CcSEcCtD
Nifedipine—Insomnia—Prednisone—hematologic cancer	1.11e-05	6.34e-05	CcSEcCtD
Nifedipine—Vision blurred—Epirubicin—hematologic cancer	1.11e-05	6.33e-05	CcSEcCtD
Nifedipine—Alopecia—Doxorubicin—hematologic cancer	1.1e-05	6.31e-05	CcSEcCtD
Nifedipine—Paraesthesia—Prednisone—hematologic cancer	1.1e-05	6.29e-05	CcSEcCtD
Nifedipine—Pruritus—Triamcinolone—hematologic cancer	1.1e-05	6.28e-05	CcSEcCtD
Nifedipine—Cough—Methotrexate—hematologic cancer	1.09e-05	6.26e-05	CcSEcCtD
Nifedipine—Mental disorder—Doxorubicin—hematologic cancer	1.09e-05	6.25e-05	CcSEcCtD
Nifedipine—Ill-defined disorder—Epirubicin—hematologic cancer	1.09e-05	6.23e-05	CcSEcCtD
Nifedipine—Vomiting—Etoposide—hematologic cancer	1.09e-05	6.22e-05	CcSEcCtD
Nifedipine—Malnutrition—Doxorubicin—hematologic cancer	1.09e-05	6.21e-05	CcSEcCtD
Nifedipine—Erythema—Doxorubicin—hematologic cancer	1.09e-05	6.21e-05	CcSEcCtD
Nifedipine—Anaemia—Epirubicin—hematologic cancer	1.08e-05	6.21e-05	CcSEcCtD
Nifedipine—Agitation—Epirubicin—hematologic cancer	1.08e-05	6.17e-05	CcSEcCtD
Nifedipine—Dyspepsia—Prednisone—hematologic cancer	1.08e-05	6.17e-05	CcSEcCtD
Nifedipine—Rash—Etoposide—hematologic cancer	1.08e-05	6.17e-05	CcSEcCtD
Nifedipine—Dermatitis—Etoposide—hematologic cancer	1.08e-05	6.16e-05	CcSEcCtD
Nifedipine—Headache—Etoposide—hematologic cancer	1.07e-05	6.13e-05	CcSEcCtD
Nifedipine—Flatulence—Doxorubicin—hematologic cancer	1.07e-05	6.12e-05	CcSEcCtD
Nifedipine—Myalgia—Methotrexate—hematologic cancer	1.07e-05	6.11e-05	CcSEcCtD
Nifedipine—Chest pain—Methotrexate—hematologic cancer	1.07e-05	6.11e-05	CcSEcCtD
Nifedipine—Arthralgia—Methotrexate—hematologic cancer	1.07e-05	6.11e-05	CcSEcCtD
Nifedipine—Tension—Doxorubicin—hematologic cancer	1.07e-05	6.1e-05	CcSEcCtD
Nifedipine—Decreased appetite—Prednisone—hematologic cancer	1.06e-05	6.09e-05	CcSEcCtD
Nifedipine—Dysgeusia—Doxorubicin—hematologic cancer	1.06e-05	6.09e-05	CcSEcCtD
Nifedipine—Rash—Prednisolone—hematologic cancer	1.06e-05	6.08e-05	CcSEcCtD
Nifedipine—Dermatitis—Prednisolone—hematologic cancer	1.06e-05	6.08e-05	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.06e-05	6.07e-05	CcSEcCtD
Nifedipine—Malaise—Epirubicin—hematologic cancer	1.06e-05	6.06e-05	CcSEcCtD
Nifedipine—Fatigue—Prednisone—hematologic cancer	1.06e-05	6.04e-05	CcSEcCtD
Nifedipine—Headache—Prednisolone—hematologic cancer	1.06e-05	6.04e-05	CcSEcCtD
Nifedipine—Discomfort—Methotrexate—hematologic cancer	1.05e-05	6.04e-05	CcSEcCtD
Nifedipine—Nervousness—Doxorubicin—hematologic cancer	1.05e-05	6.04e-05	CcSEcCtD
Nifedipine—Vertigo—Epirubicin—hematologic cancer	1.05e-05	6.03e-05	CcSEcCtD
Nifedipine—Syncope—Epirubicin—hematologic cancer	1.05e-05	6.02e-05	CcSEcCtD
Nifedipine—Leukopenia—Epirubicin—hematologic cancer	1.05e-05	6.01e-05	CcSEcCtD
Nifedipine—Back pain—Doxorubicin—hematologic cancer	1.05e-05	6.01e-05	CcSEcCtD
Nifedipine—Constipation—Prednisone—hematologic cancer	1.05e-05	5.99e-05	CcSEcCtD
Nifedipine—Muscle spasms—Doxorubicin—hematologic cancer	1.04e-05	5.97e-05	CcSEcCtD
Nifedipine—Palpitations—Epirubicin—hematologic cancer	1.04e-05	5.94e-05	CcSEcCtD
Nifedipine—Confusional state—Methotrexate—hematologic cancer	1.03e-05	5.91e-05	CcSEcCtD
Nifedipine—Loss of consciousness—Epirubicin—hematologic cancer	1.03e-05	5.9e-05	CcSEcCtD
Nifedipine—Dizziness—Triamcinolone—hematologic cancer	1.02e-05	5.87e-05	CcSEcCtD
Nifedipine—Cough—Epirubicin—hematologic cancer	1.02e-05	5.86e-05	CcSEcCtD
Nifedipine—Anaphylactic shock—Methotrexate—hematologic cancer	1.02e-05	5.86e-05	CcSEcCtD
Nifedipine—Vision blurred—Doxorubicin—hematologic cancer	1.02e-05	5.86e-05	CcSEcCtD
Nifedipine—Nausea—Etoposide—hematologic cancer	1.01e-05	5.81e-05	CcSEcCtD
Nifedipine—Feeling abnormal—Prednisone—hematologic cancer	1.01e-05	5.78e-05	CcSEcCtD
Nifedipine—Asthenia—Dexamethasone—hematologic cancer	1.01e-05	5.77e-05	CcSEcCtD
Nifedipine—Asthenia—Betamethasone—hematologic cancer	1.01e-05	5.77e-05	CcSEcCtD
Nifedipine—Ill-defined disorder—Doxorubicin—hematologic cancer	1.01e-05	5.77e-05	CcSEcCtD
Nifedipine—Nervous system disorder—Methotrexate—hematologic cancer	1e-05	5.74e-05	CcSEcCtD
Nifedipine—Anaemia—Doxorubicin—hematologic cancer	1e-05	5.74e-05	CcSEcCtD
Nifedipine—Thrombocytopenia—Methotrexate—hematologic cancer	1e-05	5.73e-05	CcSEcCtD
Nifedipine—Gastrointestinal pain—Prednisone—hematologic cancer	1e-05	5.73e-05	CcSEcCtD
Nifedipine—Nausea—Prednisolone—hematologic cancer	1e-05	5.73e-05	CcSEcCtD
Nifedipine—Chest pain—Epirubicin—hematologic cancer	9.99e-06	5.72e-05	CcSEcCtD
Nifedipine—Arthralgia—Epirubicin—hematologic cancer	9.99e-06	5.72e-05	CcSEcCtD
Nifedipine—Myalgia—Epirubicin—hematologic cancer	9.99e-06	5.72e-05	CcSEcCtD
Nifedipine—Agitation—Doxorubicin—hematologic cancer	9.98e-06	5.71e-05	CcSEcCtD
Nifedipine—Anxiety—Epirubicin—hematologic cancer	9.96e-06	5.7e-05	CcSEcCtD
Nifedipine—Pruritus—Betamethasone—hematologic cancer	9.95e-06	5.69e-05	CcSEcCtD
Nifedipine—Pruritus—Dexamethasone—hematologic cancer	9.95e-06	5.69e-05	CcSEcCtD
Nifedipine—Skin disorder—Methotrexate—hematologic cancer	9.94e-06	5.69e-05	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	9.92e-06	5.68e-05	CcSEcCtD
Nifedipine—Hyperhidrosis—Methotrexate—hematologic cancer	9.89e-06	5.66e-05	CcSEcCtD
Nifedipine—Discomfort—Epirubicin—hematologic cancer	9.87e-06	5.65e-05	CcSEcCtD
Nifedipine—Vomiting—Triamcinolone—hematologic cancer	9.85e-06	5.64e-05	CcSEcCtD
Nifedipine—Malaise—Doxorubicin—hematologic cancer	9.79e-06	5.6e-05	CcSEcCtD
Nifedipine—Rash—Triamcinolone—hematologic cancer	9.77e-06	5.59e-05	CcSEcCtD
Nifedipine—Dry mouth—Epirubicin—hematologic cancer	9.77e-06	5.59e-05	CcSEcCtD
Nifedipine—Dermatitis—Triamcinolone—hematologic cancer	9.76e-06	5.59e-05	CcSEcCtD
Nifedipine—Vertigo—Doxorubicin—hematologic cancer	9.76e-06	5.58e-05	CcSEcCtD
Nifedipine—Anorexia—Methotrexate—hematologic cancer	9.76e-06	5.58e-05	CcSEcCtD
Nifedipine—Syncope—Doxorubicin—hematologic cancer	9.74e-06	5.57e-05	CcSEcCtD
Nifedipine—Urticaria—Prednisone—hematologic cancer	9.73e-06	5.57e-05	CcSEcCtD
Nifedipine—Leukopenia—Doxorubicin—hematologic cancer	9.72e-06	5.56e-05	CcSEcCtD
Nifedipine—Headache—Triamcinolone—hematologic cancer	9.71e-06	5.56e-05	CcSEcCtD
Nifedipine—Abdominal pain—Prednisone—hematologic cancer	9.68e-06	5.54e-05	CcSEcCtD
Nifedipine—Body temperature increased—Prednisone—hematologic cancer	9.68e-06	5.54e-05	CcSEcCtD
Nifedipine—Confusional state—Epirubicin—hematologic cancer	9.66e-06	5.53e-05	CcSEcCtD
Nifedipine—Diarrhoea—Betamethasone—hematologic cancer	9.62e-06	5.51e-05	CcSEcCtD
Nifedipine—Diarrhoea—Dexamethasone—hematologic cancer	9.62e-06	5.51e-05	CcSEcCtD
Nifedipine—Palpitations—Doxorubicin—hematologic cancer	9.6e-06	5.49e-05	CcSEcCtD
Nifedipine—Oedema—Epirubicin—hematologic cancer	9.58e-06	5.48e-05	CcSEcCtD
Nifedipine—Anaphylactic shock—Epirubicin—hematologic cancer	9.58e-06	5.48e-05	CcSEcCtD
Nifedipine—Hypotension—Methotrexate—hematologic cancer	9.56e-06	5.47e-05	CcSEcCtD
Nifedipine—Loss of consciousness—Doxorubicin—hematologic cancer	9.54e-06	5.46e-05	CcSEcCtD
Nifedipine—Cough—Doxorubicin—hematologic cancer	9.48e-06	5.42e-05	CcSEcCtD
Nifedipine—Shock—Epirubicin—hematologic cancer	9.42e-06	5.39e-05	CcSEcCtD
Nifedipine—Nervous system disorder—Epirubicin—hematologic cancer	9.39e-06	5.38e-05	CcSEcCtD
Nifedipine—Thrombocytopenia—Epirubicin—hematologic cancer	9.38e-06	5.37e-05	CcSEcCtD
Nifedipine—Tachycardia—Epirubicin—hematologic cancer	9.35e-06	5.35e-05	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	9.32e-06	5.34e-05	CcSEcCtD
Nifedipine—Skin disorder—Epirubicin—hematologic cancer	9.3e-06	5.32e-05	CcSEcCtD
Nifedipine—Dizziness—Dexamethasone—hematologic cancer	9.3e-06	5.32e-05	CcSEcCtD
Nifedipine—Dizziness—Betamethasone—hematologic cancer	9.3e-06	5.32e-05	CcSEcCtD
Nifedipine—Hyperhidrosis—Epirubicin—hematologic cancer	9.26e-06	5.3e-05	CcSEcCtD
Nifedipine—Insomnia—Methotrexate—hematologic cancer	9.26e-06	5.3e-05	CcSEcCtD
Nifedipine—Arthralgia—Doxorubicin—hematologic cancer	9.24e-06	5.29e-05	CcSEcCtD
Nifedipine—Chest pain—Doxorubicin—hematologic cancer	9.24e-06	5.29e-05	CcSEcCtD
Nifedipine—Myalgia—Doxorubicin—hematologic cancer	9.24e-06	5.29e-05	CcSEcCtD
Nifedipine—Anxiety—Doxorubicin—hematologic cancer	9.21e-06	5.27e-05	CcSEcCtD
Nifedipine—Nausea—Triamcinolone—hematologic cancer	9.21e-06	5.27e-05	CcSEcCtD
Nifedipine—Paraesthesia—Methotrexate—hematologic cancer	9.19e-06	5.26e-05	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	9.18e-06	5.25e-05	CcSEcCtD
Nifedipine—Discomfort—Doxorubicin—hematologic cancer	9.13e-06	5.23e-05	CcSEcCtD
Nifedipine—Anorexia—Epirubicin—hematologic cancer	9.13e-06	5.22e-05	CcSEcCtD
Nifedipine—Dyspnoea—Methotrexate—hematologic cancer	9.12e-06	5.22e-05	CcSEcCtD
Nifedipine—Somnolence—Methotrexate—hematologic cancer	9.1e-06	5.21e-05	CcSEcCtD
Nifedipine—Dry mouth—Doxorubicin—hematologic cancer	9.04e-06	5.17e-05	CcSEcCtD
Nifedipine—Hypersensitivity—Prednisone—hematologic cancer	9.02e-06	5.16e-05	CcSEcCtD
Nifedipine—Dyspepsia—Methotrexate—hematologic cancer	9.01e-06	5.16e-05	CcSEcCtD
Nifedipine—Hypotension—Epirubicin—hematologic cancer	8.95e-06	5.12e-05	CcSEcCtD
Nifedipine—Vomiting—Betamethasone—hematologic cancer	8.94e-06	5.12e-05	CcSEcCtD
Nifedipine—Vomiting—Dexamethasone—hematologic cancer	8.94e-06	5.12e-05	CcSEcCtD
Nifedipine—Confusional state—Doxorubicin—hematologic cancer	8.94e-06	5.11e-05	CcSEcCtD
Nifedipine—Decreased appetite—Methotrexate—hematologic cancer	8.9e-06	5.09e-05	CcSEcCtD
Nifedipine—Rash—Dexamethasone—hematologic cancer	8.87e-06	5.07e-05	CcSEcCtD
Nifedipine—Rash—Betamethasone—hematologic cancer	8.87e-06	5.07e-05	CcSEcCtD
Nifedipine—Oedema—Doxorubicin—hematologic cancer	8.86e-06	5.07e-05	CcSEcCtD
Nifedipine—Anaphylactic shock—Doxorubicin—hematologic cancer	8.86e-06	5.07e-05	CcSEcCtD
Nifedipine—Dermatitis—Betamethasone—hematologic cancer	8.86e-06	5.07e-05	CcSEcCtD
Nifedipine—Dermatitis—Dexamethasone—hematologic cancer	8.86e-06	5.07e-05	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Methotrexate—hematologic cancer	8.84e-06	5.06e-05	CcSEcCtD
Nifedipine—Fatigue—Methotrexate—hematologic cancer	8.82e-06	5.05e-05	CcSEcCtD
Nifedipine—Headache—Dexamethasone—hematologic cancer	8.81e-06	5.04e-05	CcSEcCtD
Nifedipine—Headache—Betamethasone—hematologic cancer	8.81e-06	5.04e-05	CcSEcCtD
Nifedipine—Asthenia—Prednisone—hematologic cancer	8.79e-06	5.03e-05	CcSEcCtD
Nifedipine—Pain—Methotrexate—hematologic cancer	8.75e-06	5.01e-05	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	8.73e-06	4.99e-05	CcSEcCtD
Nifedipine—Shock—Doxorubicin—hematologic cancer	8.72e-06	4.99e-05	CcSEcCtD
Nifedipine—Nervous system disorder—Doxorubicin—hematologic cancer	8.69e-06	4.97e-05	CcSEcCtD
Nifedipine—Thrombocytopenia—Doxorubicin—hematologic cancer	8.68e-06	4.97e-05	CcSEcCtD
Nifedipine—Pruritus—Prednisone—hematologic cancer	8.66e-06	4.96e-05	CcSEcCtD
Nifedipine—Insomnia—Epirubicin—hematologic cancer	8.66e-06	4.96e-05	CcSEcCtD
Nifedipine—Tachycardia—Doxorubicin—hematologic cancer	8.65e-06	4.95e-05	CcSEcCtD
Nifedipine—Skin disorder—Doxorubicin—hematologic cancer	8.61e-06	4.93e-05	CcSEcCtD
Nifedipine—Paraesthesia—Epirubicin—hematologic cancer	8.6e-06	4.92e-05	CcSEcCtD
Nifedipine—Hyperhidrosis—Doxorubicin—hematologic cancer	8.57e-06	4.9e-05	CcSEcCtD
Nifedipine—Dyspnoea—Epirubicin—hematologic cancer	8.54e-06	4.89e-05	CcSEcCtD
Nifedipine—Somnolence—Epirubicin—hematologic cancer	8.51e-06	4.87e-05	CcSEcCtD
Nifedipine—Anorexia—Doxorubicin—hematologic cancer	8.45e-06	4.83e-05	CcSEcCtD
Nifedipine—Feeling abnormal—Methotrexate—hematologic cancer	8.43e-06	4.83e-05	CcSEcCtD
Nifedipine—Dyspepsia—Epirubicin—hematologic cancer	8.43e-06	4.83e-05	CcSEcCtD
Nifedipine—Diarrhoea—Prednisone—hematologic cancer	8.38e-06	4.8e-05	CcSEcCtD
Nifedipine—Gastrointestinal pain—Methotrexate—hematologic cancer	8.37e-06	4.79e-05	CcSEcCtD
Nifedipine—Nausea—Dexamethasone—hematologic cancer	8.35e-06	4.78e-05	CcSEcCtD
Nifedipine—Nausea—Betamethasone—hematologic cancer	8.35e-06	4.78e-05	CcSEcCtD
Nifedipine—Decreased appetite—Epirubicin—hematologic cancer	8.33e-06	4.76e-05	CcSEcCtD
Nifedipine—Hypotension—Doxorubicin—hematologic cancer	8.28e-06	4.74e-05	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Epirubicin—hematologic cancer	8.27e-06	4.73e-05	CcSEcCtD
Nifedipine—Fatigue—Epirubicin—hematologic cancer	8.26e-06	4.73e-05	CcSEcCtD
Nifedipine—Pain—Epirubicin—hematologic cancer	8.19e-06	4.69e-05	CcSEcCtD
Nifedipine—Constipation—Epirubicin—hematologic cancer	8.19e-06	4.69e-05	CcSEcCtD
Nifedipine—Urticaria—Methotrexate—hematologic cancer	8.13e-06	4.65e-05	CcSEcCtD
Nifedipine—Dizziness—Prednisone—hematologic cancer	8.1e-06	4.63e-05	CcSEcCtD
Nifedipine—Abdominal pain—Methotrexate—hematologic cancer	8.09e-06	4.63e-05	CcSEcCtD
Nifedipine—Body temperature increased—Methotrexate—hematologic cancer	8.09e-06	4.63e-05	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	8.07e-06	4.62e-05	CcSEcCtD
Nifedipine—Insomnia—Doxorubicin—hematologic cancer	8.02e-06	4.59e-05	CcSEcCtD
Nifedipine—Paraesthesia—Doxorubicin—hematologic cancer	7.96e-06	4.55e-05	CcSEcCtD
Nifedipine—Dyspnoea—Doxorubicin—hematologic cancer	7.9e-06	4.52e-05	CcSEcCtD
Nifedipine—Feeling abnormal—Epirubicin—hematologic cancer	7.89e-06	4.52e-05	CcSEcCtD
Nifedipine—Somnolence—Doxorubicin—hematologic cancer	7.88e-06	4.51e-05	CcSEcCtD
Nifedipine—Gastrointestinal pain—Epirubicin—hematologic cancer	7.83e-06	4.48e-05	CcSEcCtD
Nifedipine—Dyspepsia—Doxorubicin—hematologic cancer	7.8e-06	4.46e-05	CcSEcCtD
Nifedipine—Vomiting—Prednisone—hematologic cancer	7.79e-06	4.46e-05	CcSEcCtD
Nifedipine—Rash—Prednisone—hematologic cancer	7.72e-06	4.42e-05	CcSEcCtD
Nifedipine—Dermatitis—Prednisone—hematologic cancer	7.71e-06	4.41e-05	CcSEcCtD
Nifedipine—Decreased appetite—Doxorubicin—hematologic cancer	7.7e-06	4.41e-05	CcSEcCtD
Nifedipine—Headache—Prednisone—hematologic cancer	7.67e-06	4.39e-05	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	7.65e-06	4.38e-05	CcSEcCtD
Nifedipine—Fatigue—Doxorubicin—hematologic cancer	7.64e-06	4.37e-05	CcSEcCtD
Nifedipine—Urticaria—Epirubicin—hematologic cancer	7.61e-06	4.35e-05	CcSEcCtD
Nifedipine—Pain—Doxorubicin—hematologic cancer	7.58e-06	4.34e-05	CcSEcCtD
Nifedipine—Constipation—Doxorubicin—hematologic cancer	7.58e-06	4.34e-05	CcSEcCtD
Nifedipine—Abdominal pain—Epirubicin—hematologic cancer	7.57e-06	4.33e-05	CcSEcCtD
Nifedipine—Body temperature increased—Epirubicin—hematologic cancer	7.57e-06	4.33e-05	CcSEcCtD
Nifedipine—Hypersensitivity—Methotrexate—hematologic cancer	7.54e-06	4.32e-05	CcSEcCtD
Nifedipine—Asthenia—Methotrexate—hematologic cancer	7.34e-06	4.2e-05	CcSEcCtD
Nifedipine—Feeling abnormal—Doxorubicin—hematologic cancer	7.3e-06	4.18e-05	CcSEcCtD
Nifedipine—Nausea—Prednisone—hematologic cancer	7.27e-06	4.16e-05	CcSEcCtD
Nifedipine—Gastrointestinal pain—Doxorubicin—hematologic cancer	7.25e-06	4.15e-05	CcSEcCtD
Nifedipine—Pruritus—Methotrexate—hematologic cancer	7.24e-06	4.14e-05	CcSEcCtD
Nifedipine—Hypersensitivity—Epirubicin—hematologic cancer	7.06e-06	4.04e-05	CcSEcCtD
Nifedipine—Urticaria—Doxorubicin—hematologic cancer	7.04e-06	4.03e-05	CcSEcCtD
Nifedipine—Body temperature increased—Doxorubicin—hematologic cancer	7.01e-06	4.01e-05	CcSEcCtD
Nifedipine—Abdominal pain—Doxorubicin—hematologic cancer	7.01e-06	4.01e-05	CcSEcCtD
Nifedipine—Diarrhoea—Methotrexate—hematologic cancer	7e-06	4.01e-05	CcSEcCtD
Nifedipine—Asthenia—Epirubicin—hematologic cancer	6.87e-06	3.93e-05	CcSEcCtD
Nifedipine—Pruritus—Epirubicin—hematologic cancer	6.78e-06	3.88e-05	CcSEcCtD
Nifedipine—Dizziness—Methotrexate—hematologic cancer	6.77e-06	3.87e-05	CcSEcCtD
Nifedipine—Diarrhoea—Epirubicin—hematologic cancer	6.55e-06	3.75e-05	CcSEcCtD
Nifedipine—Hypersensitivity—Doxorubicin—hematologic cancer	6.53e-06	3.74e-05	CcSEcCtD
Nifedipine—Vomiting—Methotrexate—hematologic cancer	6.51e-06	3.72e-05	CcSEcCtD
Nifedipine—Rash—Methotrexate—hematologic cancer	6.45e-06	3.69e-05	CcSEcCtD
Nifedipine—Dermatitis—Methotrexate—hematologic cancer	6.45e-06	3.69e-05	CcSEcCtD
Nifedipine—Headache—Methotrexate—hematologic cancer	6.41e-06	3.67e-05	CcSEcCtD
Nifedipine—Asthenia—Doxorubicin—hematologic cancer	6.36e-06	3.64e-05	CcSEcCtD
Nifedipine—Dizziness—Epirubicin—hematologic cancer	6.33e-06	3.62e-05	CcSEcCtD
Nifedipine—Pruritus—Doxorubicin—hematologic cancer	6.27e-06	3.59e-05	CcSEcCtD
Nifedipine—Vomiting—Epirubicin—hematologic cancer	6.09e-06	3.49e-05	CcSEcCtD
Nifedipine—Nausea—Methotrexate—hematologic cancer	6.08e-06	3.48e-05	CcSEcCtD
Nifedipine—Diarrhoea—Doxorubicin—hematologic cancer	6.06e-06	3.47e-05	CcSEcCtD
Nifedipine—Rash—Epirubicin—hematologic cancer	6.04e-06	3.46e-05	CcSEcCtD
Nifedipine—Dermatitis—Epirubicin—hematologic cancer	6.03e-06	3.45e-05	CcSEcCtD
Nifedipine—Headache—Epirubicin—hematologic cancer	6e-06	3.43e-05	CcSEcCtD
Nifedipine—Dizziness—Doxorubicin—hematologic cancer	5.86e-06	3.35e-05	CcSEcCtD
Nifedipine—Nausea—Epirubicin—hematologic cancer	5.69e-06	3.26e-05	CcSEcCtD
Nifedipine—Vomiting—Doxorubicin—hematologic cancer	5.63e-06	3.22e-05	CcSEcCtD
Nifedipine—Rash—Doxorubicin—hematologic cancer	5.59e-06	3.2e-05	CcSEcCtD
Nifedipine—Dermatitis—Doxorubicin—hematologic cancer	5.58e-06	3.19e-05	CcSEcCtD
Nifedipine—Headache—Doxorubicin—hematologic cancer	5.55e-06	3.18e-05	CcSEcCtD
Nifedipine—Nausea—Doxorubicin—hematologic cancer	5.26e-06	3.01e-05	CcSEcCtD
Nifedipine—CALM3—Immune System—MAPK3—hematologic cancer	7.8e-07	7.66e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—EP300—hematologic cancer	7.78e-07	7.63e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—EP300—hematologic cancer	7.78e-07	7.63e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CB—hematologic cancer	7.76e-07	7.61e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	7.7e-07	7.56e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—MTHFR—hematologic cancer	7.68e-07	7.54e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—KRAS—hematologic cancer	7.68e-07	7.53e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAP2K1—hematologic cancer	7.63e-07	7.49e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAP2K1—hematologic cancer	7.63e-07	7.49e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	7.62e-07	7.48e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CD—hematologic cancer	7.58e-07	7.44e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CD—hematologic cancer	7.58e-07	7.44e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—SRC—hematologic cancer	7.57e-07	7.42e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—SRC—hematologic cancer	7.57e-07	7.42e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	7.55e-07	7.41e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MAPK3—hematologic cancer	7.55e-07	7.41e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MAPK3—hematologic cancer	7.55e-07	7.41e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—STAT3—hematologic cancer	7.54e-07	7.4e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—NRAS—hematologic cancer	7.52e-07	7.38e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—FGF2—hematologic cancer	7.51e-07	7.37e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CREBBP—hematologic cancer	7.49e-07	7.35e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—KRAS—hematologic cancer	7.43e-07	7.29e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—KRAS—hematologic cancer	7.43e-07	7.29e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3R1—hematologic cancer	7.4e-07	7.27e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTP1—hematologic cancer	7.3e-07	7.16e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—STAT3—hematologic cancer	7.3e-07	7.16e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—STAT3—hematologic cancer	7.3e-07	7.16e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—NRAS—hematologic cancer	7.28e-07	7.14e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—NRAS—hematologic cancer	7.28e-07	7.14e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—FGF2—hematologic cancer	7.26e-07	7.13e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—FGF2—hematologic cancer	7.26e-07	7.13e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTEN—hematologic cancer	7.26e-07	7.12e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—MAPK3—hematologic cancer	7.21e-07	7.07e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—JAK2—hematologic cancer	7.2e-07	7.06e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3R1—hematologic cancer	7.16e-07	7.03e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3R1—hematologic cancer	7.16e-07	7.03e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	7.11e-07	6.98e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTEN—hematologic cancer	7.11e-07	6.98e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CD—hematologic cancer	7.11e-07	6.97e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTEN—hematologic cancer	7.09e-07	6.96e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CREBBP—hematologic cancer	7.06e-07	6.93e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTEN—hematologic cancer	7.06e-07	6.93e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PIK3CA—hematologic cancer	7.05e-07	6.92e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MDM2—hematologic cancer	7.02e-07	6.89e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—ALB—hematologic cancer	7.02e-07	6.88e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KRAS—hematologic cancer	7.01e-07	6.88e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—MYC—hematologic cancer	7.01e-07	6.88e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CREBBP—hematologic cancer	7e-07	6.87e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—TGFB1—hematologic cancer	6.99e-07	6.86e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—MAPK3—hematologic cancer	6.97e-07	6.84e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—MAPK3—hematologic cancer	6.97e-07	6.84e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—JAK2—hematologic cancer	6.96e-07	6.83e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—JAK2—hematologic cancer	6.96e-07	6.83e-06	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PIK3CA—hematologic cancer	6.92e-07	6.79e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—EP300—hematologic cancer	6.92e-07	6.79e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ABCB1—hematologic cancer	6.91e-07	6.78e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CB—hematologic cancer	6.83e-07	6.71e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MTOR—hematologic cancer	6.83e-07	6.71e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTEN—hematologic cancer	6.83e-07	6.7e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTEN—hematologic cancer	6.83e-07	6.7e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PIK3CA—hematologic cancer	6.82e-07	6.69e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PIK3CA—hematologic cancer	6.82e-07	6.69e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MDM2—hematologic cancer	6.79e-07	6.67e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MDM2—hematologic cancer	6.79e-07	6.67e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KRAS—hematologic cancer	6.78e-07	6.66e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KRAS—hematologic cancer	6.78e-07	6.66e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—MYC—hematologic cancer	6.78e-07	6.65e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—MYC—hematologic cancer	6.78e-07	6.65e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—EP300—hematologic cancer	6.78e-07	6.65e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.77e-07	6.64e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—EP300—hematologic cancer	6.76e-07	6.64e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—TGFB1—hematologic cancer	6.76e-07	6.64e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—TGFB1—hematologic cancer	6.76e-07	6.64e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—EP300—hematologic cancer	6.74e-07	6.61e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3R1—hematologic cancer	6.71e-07	6.59e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTM1—hematologic cancer	6.71e-07	6.58e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—NCOR1—hematologic cancer	6.71e-07	6.58e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTEN—hematologic cancer	6.7e-07	6.58e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	6.7e-07	6.57e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	6.64e-07	6.51e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CB—hematologic cancer	6.61e-07	6.49e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MTOR—hematologic cancer	6.61e-07	6.49e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CB—hematologic cancer	6.61e-07	6.49e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MTOR—hematologic cancer	6.61e-07	6.49e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—ALB—hematologic cancer	6.61e-07	6.49e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—ALB—hematologic cancer	6.55e-07	6.43e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—HRAS—hematologic cancer	6.52e-07	6.4e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—EP300—hematologic cancer	6.52e-07	6.39e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—EP300—hematologic cancer	6.52e-07	6.39e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—KRAS—hematologic cancer	6.48e-07	6.35e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	6.45e-07	6.33e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—PIK3CA—hematologic cancer	6.44e-07	6.32e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1B—hematologic cancer	6.41e-07	6.29e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—EP300—hematologic cancer	6.39e-07	6.27e-06	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PIK3CA—hematologic cancer	6.35e-07	6.23e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	6.32e-07	6.21e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—HRAS—hematologic cancer	6.31e-07	6.19e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—HRAS—hematologic cancer	6.31e-07	6.19e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CASP3—hematologic cancer	6.29e-07	6.17e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL2—hematologic cancer	6.28e-07	6.16e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	6.27e-07	6.15e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—KRAS—hematologic cancer	6.26e-07	6.15e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—KRAS—hematologic cancer	6.26e-07	6.15e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—IL6—hematologic cancer	6.24e-07	6.13e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PIK3CA—hematologic cancer	6.23e-07	6.12e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PIK3CA—hematologic cancer	6.23e-07	6.12e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1B—hematologic cancer	6.2e-07	6.09e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1B—hematologic cancer	6.2e-07	6.09e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CB—hematologic cancer	6.19e-07	6.08e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTEN—hematologic cancer	6.14e-07	6.03e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCND1—hematologic cancer	6.12e-07	6e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—JUN—hematologic cancer	6.11e-07	5.99e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CASP3—hematologic cancer	6.08e-07	5.97e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CASP3—hematologic cancer	6.08e-07	5.97e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL2—hematologic cancer	6.07e-07	5.96e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL2—hematologic cancer	6.07e-07	5.96e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—IL6—hematologic cancer	6.04e-07	5.93e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—IL6—hematologic cancer	6.04e-07	5.93e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CREBBP—hematologic cancer	5.98e-07	5.87e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HRAS—hematologic cancer	5.96e-07	5.85e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—PIK3CA—hematologic cancer	5.95e-07	5.84e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—MTHFR—hematologic cancer	5.93e-07	5.82e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1A—hematologic cancer	5.92e-07	5.81e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCND1—hematologic cancer	5.92e-07	5.81e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCND1—hematologic cancer	5.92e-07	5.81e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—JUN—hematologic cancer	5.91e-07	5.8e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—JUN—hematologic cancer	5.91e-07	5.8e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PTEN—hematologic cancer	5.91e-07	5.8e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—EP300—hematologic cancer	5.86e-07	5.75e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	5.84e-07	5.73e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	5.79e-07	5.68e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAPK8—hematologic cancer	5.78e-07	5.67e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HRAS—hematologic cancer	5.77e-07	5.66e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HRAS—hematologic cancer	5.77e-07	5.66e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—AKT1—hematologic cancer	5.76e-07	5.65e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—PIK3CA—hematologic cancer	5.76e-07	5.65e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—PIK3CA—hematologic cancer	5.76e-07	5.65e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1A—hematologic cancer	5.73e-07	5.62e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1A—hematologic cancer	5.73e-07	5.62e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PTEN—hematologic cancer	5.71e-07	5.61e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PTEN—hematologic cancer	5.71e-07	5.61e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL6—hematologic cancer	5.71e-07	5.6e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	5.67e-07	5.57e-06	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—AKT1—hematologic cancer	5.66e-07	5.55e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EP300—hematologic cancer	5.63e-07	5.53e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ALB—hematologic cancer	5.6e-07	5.5e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAPK8—hematologic cancer	5.59e-07	5.48e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAPK8—hematologic cancer	5.59e-07	5.48e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—AKT1—hematologic cancer	5.57e-07	5.47e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—AKT1—hematologic cancer	5.57e-07	5.47e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL6—hematologic cancer	5.52e-07	5.42e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL6—hematologic cancer	5.52e-07	5.42e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—HRAS—hematologic cancer	5.5e-07	5.4e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SRC—hematologic cancer	5.48e-07	5.37e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EP300—hematologic cancer	5.45e-07	5.35e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EP300—hematologic cancer	5.45e-07	5.35e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	5.36e-07	5.26e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTEN—hematologic cancer	5.35e-07	5.25e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—hematologic cancer	5.33e-07	5.23e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—HRAS—hematologic cancer	5.32e-07	5.23e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—HRAS—hematologic cancer	5.32e-07	5.23e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SRC—hematologic cancer	5.3e-07	5.2e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SRC—hematologic cancer	5.3e-07	5.2e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—STAT3—hematologic cancer	5.28e-07	5.18e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NRAS—hematologic cancer	5.27e-07	5.17e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—IL6—hematologic cancer	5.27e-07	5.17e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—AKT1—hematologic cancer	5.26e-07	5.17e-06	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—AKT1—hematologic cancer	5.18e-07	5.09e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—hematologic cancer	5.16e-07	5.06e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—hematologic cancer	5.16e-07	5.06e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	5.12e-07	5.02e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—STAT3—hematologic cancer	5.11e-07	5.01e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—STAT3—hematologic cancer	5.11e-07	5.01e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—EP300—hematologic cancer	5.1e-07	5.01e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NRAS—hematologic cancer	5.1e-07	5e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NRAS—hematologic cancer	5.1e-07	5e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—IL6—hematologic cancer	5.1e-07	5e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—IL6—hematologic cancer	5.1e-07	5e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—AKT1—hematologic cancer	5.09e-07	5e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—AKT1—hematologic cancer	5.09e-07	5e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAPK3—hematologic cancer	5.05e-07	4.95e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTEN—hematologic cancer	5.04e-07	4.95e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	5.01e-07	4.92e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	5e-07	4.91e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTEN—hematologic cancer	5e-07	4.91e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CA—hematologic cancer	4.98e-07	4.89e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	4.98e-07	4.89e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	4.94e-07	4.85e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MYC—hematologic cancer	4.91e-07	4.82e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TGFB1—hematologic cancer	4.9e-07	4.8e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAPK3—hematologic cancer	4.88e-07	4.79e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAPK3—hematologic cancer	4.88e-07	4.79e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—AKT1—hematologic cancer	4.86e-07	4.77e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CA—hematologic cancer	4.82e-07	4.73e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CA—hematologic cancer	4.82e-07	4.73e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—EP300—hematologic cancer	4.81e-07	4.72e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—EP300—hematologic cancer	4.77e-07	4.68e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MYC—hematologic cancer	4.75e-07	4.66e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MYC—hematologic cancer	4.75e-07	4.66e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TGFB1—hematologic cancer	4.74e-07	4.65e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TGFB1—hematologic cancer	4.74e-07	4.65e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CA—hematologic cancer	4.73e-07	4.64e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—AKT1—hematologic cancer	4.7e-07	4.61e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—AKT1—hematologic cancer	4.7e-07	4.61e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CREBBP—hematologic cancer	4.62e-07	4.53e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KRAS—hematologic cancer	4.53e-07	4.45e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KRAS—hematologic cancer	4.39e-07	4.3e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KRAS—hematologic cancer	4.39e-07	4.3e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	4.38e-07	4.3e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	4.33e-07	4.25e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ALB—hematologic cancer	4.32e-07	4.24e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTEN—hematologic cancer	4.27e-07	4.19e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—AKT1—hematologic cancer	4.18e-07	4.1e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CA—hematologic cancer	4.17e-07	4.09e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	4.13e-07	4.06e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—AKT1—hematologic cancer	4.1e-07	4.02e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—AKT1—hematologic cancer	4.09e-07	4.01e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—EP300—hematologic cancer	4.07e-07	4e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—AKT1—hematologic cancer	4.07e-07	3.99e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—hematologic cancer	4.03e-07	3.96e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CA—hematologic cancer	4.03e-07	3.95e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CA—hematologic cancer	4.03e-07	3.95e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—AKT1—hematologic cancer	3.94e-07	3.86e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—AKT1—hematologic cancer	3.94e-07	3.86e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—hematologic cancer	3.9e-07	3.83e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—hematologic cancer	3.9e-07	3.83e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—AKT1—hematologic cancer	3.86e-07	3.79e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—HRAS—hematologic cancer	3.85e-07	3.78e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.82e-07	3.74e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CA—hematologic cancer	3.78e-07	3.71e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—HRAS—hematologic cancer	3.73e-07	3.66e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—HRAS—hematologic cancer	3.73e-07	3.66e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL6—hematologic cancer	3.69e-07	3.62e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL6—hematologic cancer	3.57e-07	3.5e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL6—hematologic cancer	3.57e-07	3.5e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	3.56e-07	3.49e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—AKT1—hematologic cancer	3.54e-07	3.47e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	3.53e-07	3.46e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—AKT1—hematologic cancer	3.4e-07	3.34e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTEN—hematologic cancer	3.3e-07	3.24e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AKT1—hematologic cancer	3.29e-07	3.23e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AKT1—hematologic cancer	3.29e-07	3.23e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—EP300—hematologic cancer	3.14e-07	3.09e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—AKT1—hematologic cancer	3.08e-07	3.03e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	3.01e-07	2.96e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AKT1—hematologic cancer	2.91e-07	2.85e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AKT1—hematologic cancer	2.88e-07	2.83e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AKT1—hematologic cancer	2.46e-07	2.42e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.33e-07	2.28e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKT1—hematologic cancer	1.9e-07	1.86e-06	CbGpPWpGaD
